2Taie S,Yokono S,Ueki M,et al. Effects of ulinastatin ( urinary trypsin inhibitor) on ATP, intracellular PH, and intracellular sodium transients during ischemia and reperfusion in the rat kidney in vivo . J Anesth, 2001,15 (1) : 33-38.
3Ono S,Ichikura T,Mochizuki H.The pathogenesis of the systemic inflammatory response syndrome and compensatory antiinflammatory response syndrome following surgical stress[J].Nippon Geka Gakkai Zasshi,2003,104:499-505.
4Levels J H,Lemaire L C,van den Ende A E,et al.Lipid compo-sition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure[J].Crit Care Med,2003,31:1647-1653.
5Matsukawa H,Hara A,Ito T,et al.Continuous arterial infusion of protease inhibitor with supplementory therapy for the patients with severe acute pancreatitis-clinical effect of arterial injection of ulinastatin[J].Nippon Shokakibyo Gakkai Zasshi,1998,95:1229-1234.
6Bone R C,Balk R A,Cerra F B,et al.The ACCP/SCCM consensus conference on sepsis and organ failure[J].Chest,1992,101:1644-1655.
7Masuda T,Sato K,Noda C,et al.Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion[J].Crit Care Med,2003,31:1987-1992.
1Levy MM, Fiink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference [ J]. Crit Care Med,2003,31 (4) :1250-1256.
2Chen CC ,Wang SS ,Tsay SH ,et al. Effects of gabexate mesilate on ser- um inflammatory cytokines in rats with acute necrotizing pancreatitis [J]. Cytokine,2006,33 (2) :95.
3Yuksel M, Okajima K, Uchiba M, et al. Gabexate mesilate, a synthetic protease inhibits lipopolysaccharide-induced tumor necrosis factor-al- pha production by inhibiting activation of both nuclear facor-kappaB andactivator protein-1 in human monocytes [ J ]. J Pharmacol Exp Ther, 2003,305( 1 ) :298.
